| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Business Officer
1 company
Kulkarni Samarth is a Chief Executive Officer at CRSP. Recent filings cover 0 purchases and 109 sales. Those positions are worth an estimated $15.5M at current prices.
Our model assigns Kulkarni Samarth a middling insider score of 68/100, based on 37 past trades. Over a 12-month horizon, 58.1% of those trades were profitable, with an average 12-month return of +7.5%.
Kulkarni Samarth's largest disclosed position is in CRSP as Chief Executive Officer, worth about $15.5M. The recent filings there lean toward selling, a net 1,049,894 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2020 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 17,275 | $64.68 | $1,117,265.50 | -9.1% | |
| May 20, 2020 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 15,000 | $65.25 | $978,683.16 | -8.0% | |
| Jun 17, 2019 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $46.00 | $920,000.00 | -10.8% | |
| Apr 29, 2019 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 20,000 | $42.03 | $840,600.00 | -10.7% | |
| Jun 1, 2018 | CRSP Crispr Therapeutics AG | Chief Executive Officer | Sale+OE | 15,000 | $69.36 | $1,040,400.00 | -9.2% | |
| Aug 30, 2017 | CRSP Crispr Therapeutics AG | Chief Business Officer | Sell | 27,154 | $20.08 | $545,161.54 | -20.3% | |
| Apr 27, 2017 | CRSP Crispr Therapeutics AG | Chief Business Officer | Sale+OE | 5,481 | $16.76 | $91,839.15 | -3.9% | |
| Apr 25, 2017 | CRSP Crispr Therapeutics AG | Chief Business Officer | Sale+OE | 11,615 | $16.78 | $194,942.20 | -8.0% | |
| Apr 20, 2017 | CRSP Crispr Therapeutics AG | Chief Business Officer | Sale+OE | 10,058 | $17.73 | $178,375.51 | -7.0% |